NCT07241195Recruiting
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
Study on the Construction of Disease Cohort for Fatty Liver in the Elderly and Its Prevention and Treatment Strategies
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
To establish a cohort of elderly fatty liver disease based on the community medical examination population. Through the large-scale cohort study, the risk factors affecting fatty liver in the elderly will be explored in depth from the aspects of lifestyle, environment and genetics, the development pattern and mechanism of fatty liver in the elderly will be analysed, and the health risk assessment system and Chinese standard for fatty liver in the elderly covering cardiovascular risk, risk of hepatic fibrosis and risk of sarcopenia will be established, so as to provide the scientific basis for the precise intervention of fatty liver in the elderly in China.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20000 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 12 Mar 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- The Affiliated Hospital of Hangzhou Normal University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07241195
What you commit to
- Study type: Observational
- Planned participants: 20000
- From 12 Mar 2026 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- ①Major disability, mental illness, major wasting disease, severe cardiac, pulmonary and renal insufficiency;
- Patients with combined primary liver cancer or other types of cancer; -③Patients who have received liver transplant or other organ transplants.
Who the study is looking for
- ① Elderly people aged ≥65 years among permanent residents (living for more than 5 years) in the survey area;
- Imaging diagnosis (ultrasound or FibroScan/FibroTouch) of fatty liver; -③ Voluntary participation in this study and signing an informed consent form.
Age in the registry: 65 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NO.518 Shangtang Road Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.